Core Laboratories (CLB) Tops Q1 EPS by 3c; Issues Solid Outlook
Tweet
Share
E-mailGet Alerts CLB Hot Sheet
Price: $11.01 -3.93%
EPS Growth %: +36.4%
Financial Fact:
General and Administrative Expense, Excluding Depreciation: 8.41M
Today's EPS Names:
CRMT, PKE, More
EPS Growth %: +36.4%
Financial Fact:
General and Administrative Expense, Excluding Depreciation: 8.41M
Today's EPS Names:
CRMT, PKE, More
Join SI Premium – FREE
Core Laboratories (NYSE: CLB) reported Q1 EPS of $0.42, $0.03 better than the analyst estimate of $0.39. Revenue for the quarter came in at $158 million versus the consensus estimate of $150.57 million.
GUIDANCE:
Core Laboratories sees Q2 2017 EPS of $0.48-$0.52, versus the consensus of $0.48.
For earnings history and earnings-related data on Core Laboratories (CLB) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Meta capex to surge in 2027, neocloud fears ’erroneous’ - SemiAnalysis
- Retail investors largely unaware of SEC semiannual reporting proposal
- S&P Global releases recast financials after Mobility spin-off
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
